Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
about
A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteinsThe immunogenicity of colorectal cancers with high-degree microsatellite instabilityImmunological Landscape and Clinical Management of Rectal CancerImmune microenvironment in colorectal cancer: a new hallmark to change old paradigmsOpportunities for immunotherapy in microsatellite instable colorectal cancerThe sentinel within: exploiting the immune system for cancer biomarkers.High-resolution analysis of HLA class I alterations in colorectal cancer.Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancers.Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancerSerum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.Immune surveillance of tumors.A microarray method for identifying tumor antigens by screening a tumor cDNA expression library against cancer sera.Interplay between DNA repair and inflammation, and the link to cancerCharacterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis.Signaling defects in anti-tumor T cellsProgression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG1.Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.Tumour heterogeneity and immune-modulationCancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation.Colon cancer and the immune system: the role of tumor invading T cells.The significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma.Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer.
P2860
Q24813048-CCD3F1C3-AEC0-4981-9A70-BF9A7FEE57E6Q24814928-0692441C-0E70-43D5-8AD0-A89C5F792120Q26768531-56EB0689-60CA-4A49-87CE-6677FB4D0FD8Q27008654-B4D39AF3-4061-4AAF-AD3A-14B4103514E3Q28066110-F1CD0FBC-BFBE-490B-8396-E2DFE318E8BEQ33221191-A02ADE50-61BE-49E1-B521-72E84F406BB4Q33259097-D58D9751-7887-466D-B04F-D73FBFDD7710Q33350212-BEB1506A-7A9B-4BF7-9600-4291892B3F31Q33552813-EAE77D92-385E-41D1-B951-8E4F565E7637Q33786764-291E07F5-2CAC-492D-ABA6-CB31F853A0E2Q34106765-4E8E17F0-962A-4CF7-9AFB-8C30FF0829B8Q34111777-6E4DDCCF-CED2-4665-9E01-2B32B6432B06Q34344817-CB210AF9-29D1-4008-92E5-F3100F26629EQ34362289-4C8358FF-4B87-4BB5-B1F3-344384CBEB89Q34579196-F05B73C6-BE4C-4CFC-93A3-98FFE1BA8CF3Q34817494-4CF28B8A-212E-421A-AB95-44379C6BE31BQ34989590-150A39A3-8E87-4CD0-985E-86291269F7B5Q35227810-86446177-095D-41A0-811B-D769F2E88560Q35584153-05EA6305-5FEB-45B0-B684-15A26BF9B55DQ36696103-23E5C3F8-07B0-4456-9EEC-A8A348DEF75AQ37063739-ABC5E2DE-187B-4919-9C85-EB4C5B1320F4Q37617095-AC4135F1-18E0-41F4-94B1-160C7774342EQ37880662-F105F7F8-E1DF-494A-9E25-8879FB17980EQ38105714-7D617C0B-45A5-44DA-BDDF-C06EFE182455Q38892904-29FFA204-3755-44CB-B78B-AA0498AA6E9DQ42725940-37148262-9C50-4FAE-8004-8598FC858BA9Q49719408-175E7A46-4C4D-4D16-BDF3-0CEC1B047BD4Q50321985-329570FD-6606-4BC2-9775-AF3999BB0D3CQ55385663-81820C45-E48C-4268-8236-4C1ABB149939
P2860
Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor-specific immunological r ...... th microsatellite instability.
@ast
Tumor-specific immunological r ...... th microsatellite instability.
@en
type
label
Tumor-specific immunological r ...... th microsatellite instability.
@ast
Tumor-specific immunological r ...... th microsatellite instability.
@en
prefLabel
Tumor-specific immunological r ...... th microsatellite instability.
@ast
Tumor-specific immunological r ...... th microsatellite instability.
@en
P2093
P1433
P1476
Tumor-specific immunological r ...... th microsatellite instability.
@en
P2093
Satoshi Okabe
Takehisa Iwai
Tomonobu Fujita
Toshiaki Ishikawa
Yasuhito Yuasa
Yuriko Suzuki
Yutaka Kawakami
P304
P407
P577
2003-09-01T00:00:00Z